Both in Pharmaceuticals
Olema Pharmaceuticals vs Lexicon Pharmaceuticals
Over the past year OLMA returned −12.7% and LXRX returned +7.4%; their daily moves had a correlation of 0.11.
OLMA −12.7% LXRX +7.4%Growth of $1, one year, split-adjusted
| Metric | OLMA | LXRX |
|---|---|---|
| Price | $7.35 | $1.46 |
| Market cap | $643.1M | $649.6M |
| Today | +3.96% | +1.39% |
| 1 month | −10.9% | −16.1% |
| 6 months | −49.8% | −11.5% |
| Year to date | −70.6% | +27.0% |
| 1 year | −18.1% | +5.8% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.7× |
| Net cash | $458.1M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 60.6% | 51.9% |
| Short % of float | 24.8% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).